Scientists test if meals change how body handles new mental health pill
NCT ID NCT07292233
Summary
This early-stage study aims to understand how eating food affects the way the body absorbs and processes a new extended-release medication (LY03020) being developed for schizophrenia and Alzheimer's disease psychosis. It involves 16 healthy adult volunteers who will take a single dose of the drug under two different conditions: with food and without food. Researchers will measure drug levels in the blood and monitor for side effects to see if taking the pill with a meal makes a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing AnDing Hospital Capital Medical University
Beijing, China
Conditions
Explore the condition pages connected to this study.